Authors
Hanaliev B.V., Barsegyan A.G.
Pirogov National Medical and Surgical Center, Moscow
Abstract
The article presents a clinical observation of patient with a large stone in the right ureteropelvic segment and a calculus in the lower third of the right ureter. The specific features of litholytic therapy in patients of this category include low compliance, diet violation, the patology of endocrine system and initial causes of recurrent urolithiasis, and a high risk of developing renal colic attacks.
Keywords: urolithiasis, uric acid nephrolithiasis, ureteral stone, ureteropelvic segment stone, oral chemolysis, litholysis.
References
1. Apolikhin OI, Sivkov AV, Moskaleva NG, Solntseva TV, Komarova VA. Analiz uronefrologicheskoi zabolevaemosti i smertnosti v Rossiiskoi Federatsii za desiatiletnii period (2008–2018 gg.) po dannym ofitsial’noi statistiki. Eksperimental’naia i klinicheskaia urologiia. 2019; 2: 2-12. (In Russ.)
2. Dosaeva LA, Shatokhina SN, Shilov EM. Diagnostika, medikamentoznoe lechenie i profilaktika mochekamennoi bolezni. Klinicheskaia meditsina. 2017; 1: 21-27. (In Russ.)
3. Zemchenkov AYu, Tomilina NA. K/DOQI obrashchaetsia k istokam khronicheskoi pochechnoi nedostatochnosti (o novom razdele Rekomendatsii K/DOQI po diagnostike, klassifikatsii i otsenke tiazhesti khronicheskikh zabolevanii pochek). Nefrologiia i dializ. 2016; 6(3): 204-220. (In Russ.)
4. Knoll T, Shubert AB, Fahlenkamp D, et al. Urolithiasis through the ages: data on more than 200,000 urinary stone analyses. J Urol. 2011; 185(4): 1304-1311. doi: 10.1016/j.juro. 2010.11.050.
5. Sanchez-Martin FM, Millan Rodriguez F, Esquena Fernandez S, et al. Incidence and prevalence of published studies about urolithiasis in Spain. A review. Actas Urol Esp. 2007; 31(5): 511-520.
6. Arias Funez F, Garcia Cuerpo E, Lovaco Castellanos F, et al. Epidemiology of urinary lithiasis in our unit. Clinical course in time and predictive factors. Arch Esp Urol. 2000; 53(4): 343-347.
7. Maalouf NM, Cameron MA, Moe OW, et al. Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol. 2007; 2(5): 883-888. doi: 10.2215/CJN.00250107.
8. Maalouf NM, Sakhaee K, Parks JH, et al. Association of urinary pH with body weight in nephrolithiasis. Kidney Int. 2004; 65(4): 1422-1425. doi: 10.1111/j.1523-1755.2004.00532.x.
9. Ekeruo WO, Tan YH, Young MD, et al. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol. 2004; 172(1): 159-163. doi: 10.1097/01.ju.0000125195.94613.22.
10. Pak CYC, Sakhaee K, Moe OW, et al. Biochemical profile of stone-forming patients with diabetes mellitus. Urology. 2003; 61(3): 523-527. doi: 10.1016/s0090-4295(02)02439-8.
11. Sakhaee K, Adams-Huet B, Moe OW, et al. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int. 2002; 62(3): 971-979. doi: 10.1046/j.1523-1755. 2002. 00530.x.
12. Alvarez-Nemegyei J, Medina-Escobedo M, Villanueva-Jorge S, et al. Prevalence and risk factors for urolithiasis in primary gout: is a reappraisal needed? J Rheumatol. 2005; 32(11): 2189-2191.
